Human Cytomegalovirus Regulates Surface Expression of the Viral Protein UL18 by Means of Two Motifs Present in the Cytoplasmic Tail1

UL18 is a trans-membrane viral protein expressed on human cytomegalovirus (HCMV)-infected cells, and its surface expression determines the interaction of infected cells with lymphocytes expressing the CD85j (LIR-1/ILT2) receptor. We previously showed that the UL18–CD85j interaction elicits activation of T lymphocytes. However, in in vitro cell models UL18 displays mostly undetectable surface expression. Thus, we asked how surface expression of UL18 is regulated. Domain-swapping experiments and construction of specific mutants demonstrated that two motifs on its cytoplasmic tail, homologous to YXXΦ and KKXX consensus sequences, respectively, are responsible for impairing UL18 surface expression. However, the presence of the whole HCMV genome, granted by HCMV infection of human fibroblasts, restored surface expression of either UL18 or chimeric proteins carrying the UL18 cytoplasmic tail, starting from the third day after infection. It is of note that the two motifs responsible for cytoplasmic retention are identical in all 17 HCMV strains examined. We disclosed a control mechanism used by the HCMV to regulate the availability of UL18 on the infected-cell surface to allow interaction with its ligand on T and NK cells.

[1]  L. Battini,et al.  Lentiviral gene delivery to CNS by spinal intrathecal administration to neonatal mice , 2006, The journal of gene medicine.

[2]  S. Olofsson,et al.  LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients , 2003, The Lancet.

[3]  S. Bruno,et al.  CD85/LIR-1/ILT2 and CD152 (Cytotoxic T Lymphocyte Antigen 4) Inhibitory Molecules Down-Regulate the Cytolytic Activity of Human CD4+ T-Cell Clones Specific forMycobacterium tuberculosis , 2001, Infection and Immunity.

[4]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[5]  J. Bonifacino,et al.  Protein targeting by tyrosine- and di-leucine-based signals: evidence for distinct saturable components , 1996, The Journal of cell biology.

[6]  P. Parham,et al.  Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.

[7]  L. Sun,et al.  Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains , 1995, Journal of virology.

[8]  Klas Kärre,et al.  Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR‐1/ILT2/CD85j , 2006, European journal of immunology.

[9]  S. Bruno,et al.  Dual Effect of CD85/Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2 and CD152 (CTLA-4) on Cytokine Production by Antigen-Stimulated Human T Cells1 , 2002, The Journal of Immunology.

[10]  P. Klenerman,et al.  Does memory improve with age? CD85j (ILT‐2/LIR‐1) expression on CD8+ T cells correlates with ‘memory inflation’ in human cytomegalovirus infection , 2005, Immunology and cell biology.

[11]  H. Browne,et al.  Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted , 1992, Journal of virology.

[12]  P. Bjorkman,et al.  Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog , 1998, The Journal of experimental medicine.

[13]  P. Cosson,et al.  New COP1‐binding motifs involved in ER retrieval , 1998, The EMBO journal.

[14]  F. Gage,et al.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  William Arbuthnot Sir Lane,et al.  The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.

[16]  H. Vally,et al.  Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo , 1997, Nature.

[17]  P. Tomasec,et al.  The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1− NK Cells1 , 2007, The Journal of Immunology.

[18]  C. Maliszewski,et al.  The MHC class I binding proteins LIR‐1 and LIR‐2 inhibit Fc receptor‐mediated signaling in monocytes , 1998, European journal of immunology.

[19]  S. Jonjić,et al.  Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection , 1998, The Journal of experimental medicine.

[20]  A. West,et al.  Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). , 2000, Immunity.

[21]  A. McMichael,et al.  Virus infections: escape, resistance, and counterattack. , 2001, Immunity.

[22]  A. Gruhler,et al.  A comparison of viral immune escape strategies targeting the MHC class I assembly pathway , 1999, Immunological reviews.

[23]  T. Bellón,et al.  Mutational Analysis of Immunoreceptor Tyrosine-Based Inhibition Motifs of the Ig-Like Transcript 2 (CD85j) Leukocyte Receptor1 , 2002, The Journal of Immunology.

[24]  Leszek Rychlewski,et al.  ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins , 2003, Nucleic Acids Res..

[25]  Y. Sung,et al.  The MHC Class I Homolog of Human Cytomegalovirus Is Resistant to Down-Regulation Mediated by the Unique Short Region Protein (US)2, US3, US6, and US11 Gene Products1 , 2002, The Journal of Immunology.

[26]  H. Reyburn,et al.  Genetic Variability of the Major Histocompatibility Complex Class I Homologue Encoded by Human Cytomegalovirus Leads to Differential Binding to the Inhibitory Receptor ILT2 , 2005, Journal of Virology.

[27]  P. Griffiths,et al.  Transcription of the human cytomegalovirus natural killer decoy gene, UL18, in vitro and in vivo. , 1998, The Journal of general virology.

[28]  M. Ho,et al.  Epidemiology of cytomegalovirus infections. , 1990, Reviews of infectious diseases.

[29]  S. Pileri,et al.  Specific Recognition of the Viral Protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T Cells Mediates the Non-MHC-Restricted Lysis of Human Cytomegalovirus-Infected Cells1 , 2004, The Journal of Immunology.

[30]  A. Antonsson,et al.  Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus. , 2001, The Journal of general virology.

[31]  P. Tomasec,et al.  Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. , 2005, The Journal of general virology.

[32]  G. Anastasi,et al.  The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions1 , 2000, The Journal of Immunology.

[33]  S. Beck,et al.  Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens , 1988, Nature.

[34]  C. Ahn,et al.  Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. , 2004, Biochemical and biophysical research communications.

[35]  J. Bonifacino,et al.  Interaction of tyrosine-based sorting signals with clathrin-associated proteins. , 1995, Science.

[36]  M. Nardini,et al.  Dissecting the Structural Determinants of the Interaction between the Human Cytomegalovirus UL18 Protein and the CD85j Immune Receptor1 , 2008, The Journal of Immunology.

[37]  P. Tomasec,et al.  Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141 , 2005, Nature Immunology.

[38]  M. Colonna,et al.  Ig-Like Transcript 2 (ILT2)/Leukocyte Ig-Like Receptor 1 (LIR1) Inhibits TCR Signaling and Actin Cytoskeleton Reorganization1 , 2001, The Journal of Immunology.

[39]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[40]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[41]  O. Mandelboim,et al.  The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.

[42]  S. Beck,et al.  A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin , 1990, Nature.

[43]  I. Marugán,et al.  Reconstitution of lymphocyte populations and cytomegalovirus viremia or disease after allogeneic peripheral blood stem cell transplantation , 2003, Journal of medical virology.

[44]  Paul Horton,et al.  Better Prediction of Protein Cellular Localization Sites with the it k Nearest Neighbors Classifier , 1997, ISMB.

[45]  A. McMichael,et al.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. , 2000, Science.

[46]  Hanah Margalit,et al.  Host Immune System Gene Targeting by a Viral miRNA , 2007, Science.

[47]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[48]  E. Carbone,et al.  Increased Expression of Leukocyte Ig-Like Receptor-1 and Activating Role of UL18 in the Response to Cytomegalovirus Infection1 , 2007, The Journal of Immunology.

[49]  P. Moss,et al.  Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules. , 2005, The Journal of infectious diseases.

[50]  Jae U. Jung,et al.  Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.

[51]  S. Emr,et al.  Signal-mediated retrieval of a membrane protein from the Golgi to the ER in yeast , 1994, The Journal of cell biology.